MedTechnology

Can Johnson & Johnson’s $550 Million Vision Care Expansion Drive Local Growth and Innovation?

23 January 2026 Executive Summary Johnson & Johnson’s Vision Care division is advancing a major U.S. expansion project,…

ByByAnuja Singh Jan 24, 2026

Can Johnson & Johnson Hit $100 Billion in Revenue Despite U.S. Pricing Pressures?

23 January 2026 Executive Summary Johnson & Johnson (J&J) has issued a bullish 2026 revenue forecast, projecting nearly…

ByByAnuja Singh Jan 24, 2026

Does the U.S. Exit from WHO Redefine Global Health Governance? Washington Completes Historic Withdrawal

23 January 2026 Executive Summary The United States has formally completed its withdrawal from the World Health Organization…

ByByAnuja Singh Jan 24, 2026

Does the U.S. Exit from WHO Redefine Global Health Governance? Washington Completes Historic Withdrawal

23 January 2026 Executive Summary The United States has formally completed its withdrawal from the World Health Organization…

ByByAnuja Singh Jan 24, 2026
Image Not Found

Will Johnson & Johnson’s 2025 Earnings Reinforce Confidence in Its Pharma-Led Growth Engine?

Late January 2026 | Full-Year 2025 Earnings Preview | Diversified Pharma Outlook Johnson & Johnson (J&J) is set…

ByByAnuja Singh Jan 26, 2026

Will Roche’s 2025 Earnings Reset the Narrative for 2026 Growth and Pipeline Confidence?

January 29, 2026 | Full-Year Earnings | Big Pharma Outlook Roche is set to publish its full-year 2025…

ByByAnuja Singh Jan 26, 2026
Scroll to Top